Danaher Corp. (DHR)
230.25
+3.91
(+1.73%)
USD |
NYSE |
Nov 06, 16:00
230.25
0.00 (0.00%)
Pre-Market: 20:00
Danaher Free Cash Flow : 5.727B for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | 5.727B |
| June 30, 2026 | 5.466B |
| March 31, 2026 | 5.291B |
| December 31, 2025 | 5.26B |
| September 30, 2025 | 5.017B |
| June 30, 2025 | 4.862B |
| March 31, 2025 | 4.902B |
| December 31, 2024 | 5.296B |
| September 30, 2024 | 4.978B |
| June 30, 2024 | 5.102B |
| March 31, 2024 | 5.548B |
| December 31, 2023 | 5.781B |
| September 30, 2023 | 6.842B |
| June 30, 2023 | 7.236B |
| March 31, 2023 | 7.364B |
| December 31, 2022 | 7.401B |
| September 30, 2022 | 7.068B |
| June 30, 2022 | 7.051B |
| March 31, 2022 | 7.162B |
| December 31, 2021 | 7.064B |
| September 30, 2021 | 7.056B |
| June 30, 2021 | 6.876B |
| March 31, 2021 | 6.350B |
| December 31, 2020 | 5.417B |
| September 30, 2020 | 4.444B |
| Date | Value |
|---|---|
| June 30, 2020 | 3.712B |
| March 31, 2020 | 3.439B |
| December 31, 2019 | 3.316B |
| September 30, 2019 | 3.479B |
| June 30, 2019 | 3.446B |
| March 31, 2019 | 3.311B |
| December 31, 2018 | 3.438B |
| September 30, 2018 | 3.004B |
| June 30, 2018 | 3.167B |
| March 31, 2018 | 3.148B |
| December 31, 2017 | 2.858B |
| September 30, 2017 | 2.679B |
| June 30, 2017 | 2.415B |
| March 31, 2017 | 2.684B |
| December 31, 2016 | 2.932B |
| September 30, 2016 | 3.488B |
| June 30, 2016 | 3.590B |
| March 31, 2016 | 3.415B |
| December 31, 2015 | 3.169B |
| September 30, 2015 | 3.195B |
| June 30, 2015 | 3.296B |
| March 31, 2015 | 3.185B |
| December 31, 2014 | 3.161B |
| September 30, 2014 | 3.016B |
| June 30, 2014 | 2.975B |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Thermo Fisher Scientific, Inc. | 7.596B |
| Agilent Technologies, Inc. | 1.267B |
| Bio-Rad Laboratories, Inc. | 353.10M |
| Revvity, Inc. | 588.31M |
| Bruker Corp. | 244.70M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.886B |
| Cash from Investing (Quarterly) | -300.00M |
| Cash from Financing (Quarterly) | -262.00M |
| Free Cash Flow Per Share (Quarterly) | 2.308 |
| Free Cash Flow to Equity (Quarterly) | 1.707B |
| Free Cash Flow to Firm (Quarterly) | 1.775B |
| Free Cash Flow Yield | 3.51% |